To understand how decentralized clinical trials (DCTs) may increase patient participation and diversity, we need to understand what they are and how they differ from traditional, centralized clinical trials.
Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Development biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Tyler Jacks, Ph.D., after 19 years. The director role will be taken over by
Matthew Vander Heiden, M.D., Ph.D., a professor of biology at MIT and a medical oncologist at Dana-Farber Cancer Institute. He became a member of the Koch Institute in 2010 and took over for Jacks on Thursday, MIT said. Jacks will continue to lead the Bridge Project, which unites bioegnineers, cancer scientists and clinical oncologists from the Koch Institute and the Dana-Farber/Harvard Cancer Center.
> Atara Biotherapeutics ushered
Amie Krause into the role of senior vice president and chief people officer April 2. Since joining the company, Krause has been the driving force behind Atara’s human people department, advocating for employees across the organization. She doubles as a founding leader of Atara’s Women’s Alliance and is part of the Healthcare Businesswomen’s Association. Before signing on with Atara, Krause held several top human resources roles at Amgen, including HR lead for the